₹330 5.1 1.6%
Last Trade - 13/04/21
| Market Cap | £15.1m |
| Enterprise Value | £19.5m |
| Revenue | £12.5m |
| Position in Universe | 1522nd / 3106 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,182 | 1,366 | 1,485 | 1,533 | 1,700 | 1,760 | 2,000 | +8.3% | |||
| +106.1 | -91.5 | +1,409 | -11.0 | +75.6 | +13.3 | +17.4 | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Dr. Agarwal's Eye Hospital Limited is an eye care company. The Company is engaged in providing hospital and health-related services. The Company also provides nursing homes; clinics; medical, research and other institutions and establishments for eye care and treatment, and other healthcare facilities. The Company is also engaged in hospital-related trading and other activities. The Company offers services related to cataract, glaucoma, laser correction, cornea and refractive, retina, squint, pediatric ophthalmology, neuro ophthalmology, uvea, and orbit and oculoplasty. The Company is also engaged in academics, such as fellowship and optometry. The Company offers its services in various locations in India, including Chennai, Bangalore, Hyderabad, Rajasthan, Andaman and Odisha, and in international locations, including Cambodia, Madagascar, Mauritius, Mozambique, Nigeria, Rwanda, Seychelles, Uganda and Zambia.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | April 22, 1994 |
| Public Since | January 23, 1995 |
| No. of Shareholders: | 2,930 |
| No. of Employees: | 772 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange | Bombay Stock Exchange |
| Shares in Issue | 4,700,000 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 3rd Floor Buhari Towers,No4 Moores Road Off Greams Road, Near:Asan Memorial School, CHENNAI, 600086, India |
| Web | http://www.dragarwal.com/ |
| Phone | +91 44 39916669 |
| Contact | () |
| Auditors | Deloitte Haskins & Sells |
As of 13/04/21, shares in Dr Agarwal's Eye Hospital are trading at ₹330, giving the company a market capitalisation of £15.1m. This share price information is delayed by 15 minutes.
Shares in Dr Agarwal's Eye Hospital are currently trading at ₹330 and the price has moved by 53.88% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dr Agarwal's Eye Hospital price has moved by -3.23% over the past year.
Of the analysts with advisory recommendations for Dr Agarwal's Eye Hospital, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Dr Agarwal's Eye Hospital is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Dr Agarwal's Eye Hospital is scheduled to issue upcoming financial results on the following dates:
Dr Agarwal's Eye Hospital does not currently pay a dividend.
Dr Agarwal's Eye Hospital does not currently pay a dividend.
Dr Agarwal's Eye Hospital does not currently pay a dividend.
To buy shares in Dr Agarwal's Eye Hospital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Dr Agarwal's Eye Hospital are currently trading at ₹330, giving the company a market capitalisation of £15.1m.
Here are the trading details for Dr Agarwal's Eye Hospital:
Based on an overall assessment of its quality, value and momentum, Dr Agarwal's Eye Hospital is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Dr Agarwal's Eye Hospital.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dr Agarwal's Eye Hospital. Over the past six months, the relative strength of its shares against the market has been 8.25%. At the current price of ₹330, shares in Dr Agarwal's Eye Hospital are trading at 21.46% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Dr Agarwal's Eye Hospital PE ratio based on its reported earnings over the past 12 months is 3.57k. The shares are currently trading at ₹330.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Dr Agarwal's Eye Hospital's management team is headed by:
Here are the top five shareholders of Dr Agarwal's Eye Hospital based on the size of their shareholding:
